APA

Lee J. L., Kim M. K., Park I., Ahn J., Lee D. H., Ryoo H. M., Song C., Hong B., Hong J. H. & Ahn H. (20160818). RandomizEd phase II trial of Sunitinib four weeks on and two weeks off versus Two weeks on and One week off in metastatic clear-cell type REnal cell carcinoma: RESTORE trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Lee J L, Kim M K, Park I, Ahn J-H, Lee D H, Ryoo H M, Song C, Hong B, Hong J H and Ahn H. 20160818. RandomizEd phase II trial of Sunitinib four weeks on and two weeks off versus Two weeks on and One week off in metastatic clear-cell type REnal cell carcinoma: RESTORE trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Lee J. L., Kim M. K., Park I., Ahn J., Lee D. H., Ryoo H. M., Song C., Hong B., Hong J. H. and Ahn H. (20160818). RandomizEd phase II trial of Sunitinib four weeks on and two weeks off versus Two weeks on and One week off in metastatic clear-cell type REnal cell carcinoma: RESTORE trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Lee J L, Kim M K, Park I, Ahn J-H, Lee D H, Ryoo H M, Song C, Hong B, Hong J H and Ahn H. RandomizEd phase II trial of Sunitinib four weeks on and two weeks off versus Two weeks on and One week off in metastatic clear-cell type REnal cell carcinoma: RESTORE trial. : Annals of oncology : official journal of the European Society for Medical Oncology. 20160818.